Rakesh Kundu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rakesh Kundu has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Chandrani Fouzder
Visva Bharati, Dept Zool, Cell Signaling Lab, Santini Ketan 731235, India
12 shared publicationsAlpana Mukhuty
Visva Bharati, Dept Zool, Cell Signaling Lab, Santini Ketan 731235, India
7 shared publicationsChandan Malick
Cell Signaling Laboratory, Visva-Bharati University, Santiniketan 731 235, India
7 shared publicationsSamir Bhattacharya
Molecular Endocrinology Laboratory, Department of Zoology, Visva-Bharati University, Santiniketan, India
7 shared publicationsSandip Mukherjee
Molecular Endocrinology Laboratory, Department of Zoology, Siksha- Bhavana, Visva-Bharati University, Santiniketan 731 235, India; Department of Pharmacology and Physiology, Saint Louis University, School of Medicine, Saint Louis, Missouri 63104, USA
7 shared publicationsSuman Dasgupta
Centre for Advanced Studies in Zoology, School of Life Science, Visva-Bharati University, Santiniketan, West Bengal, India
6 shared publications
Latest Publications
- Open Access
- 16 January 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1540999
Editorial: Metaflammation in obesity and diabetes
Lifestyle diseases are indeed becoming life-threatening. Obesity and diabetes are now considered as two major inflammatory diseases that were in disguised over the years as only metabolic diseases. Now there are growing interests in dissecting the role of metaflammation as well as inflammation as a cause and/or consequence for its direct contribution in the pathogenesis and/or pathophysiology of these life-threatening diseases. Since the last decade, cutting-edge research demonstrated obesity as one of the key mediators and predisposing factors in the context of inflammatory pathogenesis of diabetes and beyond, including cancer. Intriguingly, obesity has been presented as the promoter of diabetes as well as cancer through the experimental and clinical research conducted throughout the last 10 years [1][2].Keeping this in mind, the present research topic was conceived with an aim to present the current updates on the topics ranging from the mechanistic insights of inflammatory consequences induced in obesity, signaling defects/dysregulation in cell death pathways and endocrine network, response to infectious agents etc. relevant to clinical progression of diabetes. A total of 7 contributions from 8 countries were received that include 4 original research and 3 review articles. All the 3 reviews and a research article described the mechanistic insights of metaflammation in diabetes and possible therapeutic options while rest of the articles were emphasized on obesity.Low-grade persistent inflammation in obesity is linked to a number of serious health setbacks including diabetes. In compliance to the aim of the present issues, the study by Uroić et al. (https://doi.org/10.3389/fendo.2024.1335371) have revealed a significantly close association between the expression of chemokine ligand/receptor and pathological abnormalities of obesity as well as obesity-induced diabetes viz. abundance of CCR4 + T lymphocytes vs vascular inflammation, CXCR4 + subsets vs albuminuria as well as CXCR3 + T lymphocytes vs dyslipidemia and these chemokine axes have been proposed as potential therapeutic targets. In addition, obese conditions due to overfeeding during early post-natal period has been demonstrated to signal polycystic ovary syndrome (PCOS) and insulin resistance through evoking proinflammatory responses by activating NLRP3 followed by an elevation in IL-1β expression and deactivating AMPK as experimentally documented by Veličković et al. (https://doi.org/10.3389/fendo.2024.1402905). In healthy individuals, antiinflammatory mediators reverse the proinflammatory episodes. Adiponectin (ADP) synthesized in adipocytes is known to act as an anti-inflammatory adipokine that links lipid metabolism and glucose homeostasis to regulate energy balance as well insulin-secretion to prevent obesity [3]. However, a cross-sectional study by Nielsen et al. Prevalence of obesity due to changes in life-style, feed habits and environmental changes is indeed increasing and reports new fatal outcomes are also emerging from both developed and developing countries. In particular, obesity-induced cancer is also threating the world with increasing prevalence with its different subtypes [8], especially colorectal cancer.Interestingly, obesity-induced inflammation and further complications described in this editorial are majorly linked to Toll-like receptor 4 (TLR4) as summarized by Figure 1. Whilst proinflammatory cytokines drives tumorigenesis through inflammation-dysplasianeoplasia sequel. Created in https://BioRender.com.Although
- 16 January 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1540999
Open AccessEditorial: Metaflammation in obesity and diabetes
Lifestyle diseases are indeed becoming life-threatening. Obesity and diabetes are now considered as two major inflammatory diseases that were in disguised over the years as only metabolic diseases. Now there are growing interests in dissecting the role of metaflammation as well as inflammation as a cause and/or consequence for its direct contribution in the pathogenesis and/or pathophysiology of these life-threatening diseases. Since the last decade, cutting-edge research demonstrated obesity as one of the key mediators and predisposing factors in the context of inflammatory pathogenesis of diabetes and beyond, including cancer. Intriguingly, obesity has been presented as the promoter of diabetes as well as cancer through the experimental and clinical research conducted throughout the last 10 years [1][2].Keeping this in mind, the present research topic was conceived with an aim to present the current updates on the topics ranging from the mechanistic insights of inflammatory consequences induced in obesity, signaling defects/dysregulation in cell death pathways and endocrine network, response to infectious agents etc. relevant to clinical progression of diabetes. A total of 7 contributions from 8 countries were received that include 4 original research and 3 review articles. All the 3 reviews and a research article described the mechanistic insights of metaflammation in diabetes and possible therapeutic options while rest of the articles were emphasized on obesity.Low-grade persistent inflammation in obesity is linked to a number of serious health setbacks including diabetes. In compliance to the aim of the present issues, the study by Uroić et al. (https://doi.org/10.3389/fendo.2024.1335371) have revealed a significantly close association between the expression of chemokine ligand/receptor and pathological abnormalities of obesity as well as obesity-induced diabetes viz. abundance of CCR4 + T lymphocytes vs vascular inflammation, CXCR4 + subsets vs albuminuria as well as CXCR3 + T lymphocytes vs dyslipidemia and these chemokine axes have been proposed as potential therapeutic targets. In addition, obese conditions due to overfeeding during early post-natal period has been demonstrated to signal polycystic ovary syndrome (PCOS) and insulin resistance through evoking proinflammatory responses by activating NLRP3 followed by an elevation in IL-1β expression and deactivating AMPK as experimentally documented by Veličković et al. (https://doi.org/10.3389/fendo.2024.1402905). In healthy individuals, antiinflammatory mediators reverse the proinflammatory episodes. Adiponectin (ADP) synthesized in adipocytes is known to act as an anti-inflammatory adipokine that links lipid metabolism and glucose homeostasis to regulate energy balance as well insulin-secretion to prevent obesity [3]. However, a cross-sectional study by Nielsen et al. Prevalence of obesity due to changes in life-style, feed habits and environmental changes is indeed increasing and reports new fatal outcomes are also emerging from both developed and developing countries. In particular, obesity-induced cancer is also threating the world with increasing prevalence with its different subtypes [8], especially colorectal cancer.Interestingly, obesity-induced inflammation and further complications described in this editorial are majorly linked to Toll-like receptor 4 (TLR4) as summarized by Figure 1. Whilst proinflammatory cytokines drives tumorigenesis through inflammation-dysplasianeoplasia sequel. Created in https://BioRender.com.Although
- 9 September 2024
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 23 (9) , 1771-1782
An insight into the role of ESIPT/TICT-based antioxidant flavone analogues in fluoro-probing diabetes-induced viscosity changes: a unified experimental and theoretical endeavour
Potent antioxidants, like 3-hydroxy flavones, attracted considerable attention due to their excited state intramolecular proton transfer (ESIPT)-based fluorescence behaviour. This article is an interesting demonstration of a series of synthetic 3-hydroxy flavone analogues having high antioxidant activity as molecular rotor-like viscosity probes. Among these flavone analogues, 4′-N,N-dimethylamino-3-hydroxy flavone (3) is the most potent one, showing the twisted intramolecular charge transfer (TICT)-dependent fluoroprobing activity toward the blood viscosity changes associated with diabetes and free fatty acids (FFA)-induced nuclear viscosity changes of MIN6 cells. The TICT dynamics of (3), which instigates its viscosity probing activity, was comprehended with the help of DFT-based computational studies. Abnormal cellular viscosity changes are the pathological traits for various diseases, and non-toxic flavone-based viscosity probes can be useful for diagnosing such pathological conditions. Graphical abstract
- 9 September 2024
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 23 (9) , 1771-1782
An insight into the role of ESIPT/TICT-based antioxidant flavone analogues in fluoro-probing diabetes-induced viscosity changes: a unified experimental and theoretical endeavour
Potent antioxidants, like 3-hydroxy flavones, attracted considerable attention due to their excited state intramolecular proton transfer (ESIPT)-based fluorescence behaviour. This article is an interesting demonstration of a series of synthetic 3-hydroxy flavone analogues having high antioxidant activity as molecular rotor-like viscosity probes. Among these flavone analogues, 4′-N,N-dimethylamino-3-hydroxy flavone (3) is the most potent one, showing the twisted intramolecular charge transfer (TICT)-dependent fluoroprobing activity toward the blood viscosity changes associated with diabetes and free fatty acids (FFA)-induced nuclear viscosity changes of MIN6 cells. The TICT dynamics of (3), which instigates its viscosity probing activity, was comprehended with the help of DFT-based computational studies. Abnormal cellular viscosity changes are the pathological traits for various diseases, and non-toxic flavone-based viscosity probes can be useful for diagnosing such pathological conditions. Graphical abstract
- 22 August 2024
- Published by Elsevier in Toxicology in Vitro
- Vol. 101, 105921
Silencing Nrf2 in cisplatin resistant non-small cell lung cancer cells augments sensitivity towards EGFR inhibitor
- 22 August 2024
- Published by Elsevier in Toxicology in Vitro
- Vol. 101, 105921
Silencing Nrf2 in cisplatin resistant non-small cell lung cancer cells augments sensitivity towards EGFR inhibitor
- 22 November 2023
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 581, 112112
Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
- 22 November 2023
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 581, 112112
Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
- Open Access
- 11 April 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (5) , 321-333
DPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes
Diabetic patients are at particular risk of severe COVID-19. Human dipeptidyl peptidase-4 (DPP-4) is a membrane-bound aminopeptidase that regulates insulin release by inactivating incretin. DPP-4 i... Tweetable abstract DPP-4 inhibitors could be promising repurposed drugs to minimize inflammatory pathogenesis and disease severity in COVID-19/diabetes comorbidity.
- 11 April 2023
- Published by Taylor & Francis in Future Virology
- Vol. 18 (5) , 321-333
Open AccessDPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes
Diabetic patients are at particular risk of severe COVID-19. Human dipeptidyl peptidase-4 (DPP-4) is a membrane-bound aminopeptidase that regulates insulin release by inactivating incretin. DPP-4 i... Tweetable abstract DPP-4 inhibitors could be promising repurposed drugs to minimize inflammatory pathogenesis and disease severity in COVID-19/diabetes comorbidity.
- 23 January 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 647, 55-61
FFA-Fetuin-A regulates DPP-IV expression in pancreatic beta cells through TLR4-NFkB pathway
- 23 January 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 647, 55-61
FFA-Fetuin-A regulates DPP-IV expression in pancreatic beta cells through TLR4-NFkB pathway
- Open Access
- 1 February 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 2 (1) , 100203
TGR5 potentiates GLP-1 secretion and cause pancreatic islet regeneration in response to Tithonia diversifolia saponin-rich extract in diabetic model mice
- 1 February 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 2 (1) , 100203
Open AccessTGR5 potentiates GLP-1 secretion and cause pancreatic islet regeneration in response to Tithonia diversifolia saponin-rich extract in diabetic model mice
- 1 January 2022
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1248, 131511
Understanding the Role of Flavonoid Based Small Molecules in Modulating the Oncogenic Protein-Protein Interactions: A Quest for Therapeutic Arsenal
- 1 January 2022
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1248, 131511
Understanding the Role of Flavonoid Based Small Molecules in Modulating the Oncogenic Protein-Protein Interactions: A Quest for Therapeutic Arsenal